Microbiome and Premature Ovarian Insufficiency
A legfontosabb adatok
- Ki végzi
- Westlake University
- Hol
- Kína2 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 39 fő vett részt
- Kezdés
- 2025. máj. 13.
- Befejezés
- 2025. dec. 18.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A regiszteradat frissítve
- 2026. június 26.
Ki vehet részt
- Életkor
- 20 év – 40 év
- Nem
- Csak nők
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 26 feltétel megnézéseKevesebb
Ki vehet részt
- (For POI patients)
- Women aged 20 to 40 years at screening visit
- Clinical diagnosis of premature ovarian insufficiency (based on diagnostic criteria: 25 < FSH ≤ 40 IU/L, reduced follicle count and abnormal follicle development by ultrasound)
- Able to provide informed consent; (For healthy volunteers)
- Age (±2 years) and sex-matched healthy control individuals for each POI patient
- Able to provide informed consent
Ki nem vehet részt
- Use of hormone therapy (such as HRT) within the past 6 months
- Use of antibiotics in the past 3 months before sample collection
- Use of hormone therapy (e.g., loratadine, oral contraceptives, etc.) within the past 6 months
- Use of antibiotics in the past 3 months before sample collection
- Family history of premature ovarian insufficiency
- Serious illness (e.g., heart failure or malignancy)
- Smoking more than 15 cigarettes per day or history of alcohol or drug addiction
- Inflammatory gastrointestinal diseases
- Chronic diseases that may affect the gut microbiota (e.g., diabetes, cirrhosis, or cardiovascular disease)
- Blood or autoimmune diseases, or use of immunosuppressants in the past 3 months
- Have a history of infertility or recurrent miscarriage
- Inflammatory gastrointestinal diseases
- Smoking more than 15 cigarettes per day or history of alcohol or drug addiction
- Chronic diseases that may affect the gut microbiota (e.g., diabetes, cirrhosis, or cardiovascular disease)
- Blood or autoimmune diseases, or use of immunosuppressants in the past 3 months
- (For POI patients)
- Chronic constipation; (For healthy volunteers)
- Pregnant or breastfeeding
- Chronic constipation
- Participating in other clinical trials
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study investigates the differences in gut and vaginal microbiota between women with premature ovarian insufficiency (POI) and healthy volunteers. POI refers to the reduction in ovarian function before the age of 40, leading to irregular or absent menstruation and decreased estrogen levels, which can significantly affect women's reproductive and overall health. Recent research has suggested that gut microorganisms may influence the balance of steroid hormones through various metabolic pathways. Additionally, certain vaginal bacteria appear enriched in patients with POI, but whether these microorganisms directly impact ovarian function, and how, remains unclear. This study also seeks to address the underexplored role of fungi within the human microbiome. To comprehensively compare differences in gut and vaginal microbiota, the study will recruit 20 women with POI and 20 healthy controls. Both demographic and clinical information will be collected, along with biological samples including blood, urine, stool, and vaginal swabs.
A vizsgálat 2 csoportja
- POI
Premature ovarian insufficiency
- CTL
Healthy control
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Case-Control Study of Gut and Vaginal Microbiota Differences Between Premature Ovarian Insufficiency Patients and Healthy Controls
- A regiszteradat frissítve
- 2026. június 26.